Groups of female Donryu rats were inoculated intraperitoneally with 1×107 Yoshida ascites sarcoma cells. Animals were then subjected to the daily treatment with subcutaneous administration of water soluble prednisolone (P). Injection of P was initiated 2 days after inoculation in Group I, while Group II started to receive treatment immediately following inoculation. Each Group was further devided into three subgroups of A, B, and C, to which 1 mg, 0.2 mg, and 0.05 mg of P per 100 g of body weight were administerd, respectively. The result were summerized as follows : 1) Growth rate of the tumor cells was significantly suppressed in A and B rats of Group I and in all subgroups of Group II. This initial suppression, however, was transient and was followed by a rebound increase in the 5th or 6th day after inoculation.2) On the 4th day, when the cell growth was still suppressed, both mitotic index and 3H-TdR pulse labeling index of the tumor cells were significantly decreased in all animals treated with P. The duration of mitosis remained unaffected, being 1 hour. Although no difference was observed in DNA synthetic time among the rats of Group I, it was significantly prolonged in Group II. G2 duration was 2 hours in both P-treated and control rats. Thus, treatment with P appeared to prolong the duration of G1 phase proportionally to the dosis administered. Compartment size of non-proliferative cells was found to be enlarged significantly, when the growth rate was retarded by the treatment.3) In Group II, in vivo 3H-uridine labeling index was significantly depressed on the 4th day, while the mean grain counts were nearly equal to the control. However, the amount of 3H-uridine incorporated into RNA fraction of tumor cells was significantly less in P-treated rats than in the control. Thereafter, the incorporation increased in the P-treated rats, and decreased in the control. On the 5th day after inoculation, no significant difference became appearant between P-treated and control rats.4) It was suggested that P mainly affects the pre-DNA synthetic phase of Yoshida ascites tumor cells and inhibits the initiation of DNA synthesis. These effects were weak, though definitive, and seemed to disappear within several days despite the continued administration.